Page last updated: 2024-12-11

acefyllin piperazinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID76959346
MeSH IDM0081283

Synonyms (35)

Synonym
piperazine theophyllineacetate
etaphylline
etophylate
acefilina piperazina [inn-spanish]
dynaphylline
theophyllin-7-acetic acid piperazine salt
acefyllin piperazinate
acepifylline
piperazine theophylline ethanoate
1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7h-purine-7-acetic acid,compound with piperazine (2:1)
acefillina piperazina [dcit]
einecs 242-614-3
piperazine 7-theophyllineacetate
aethaphyllinium
etafillina
minophylline
acefylline piperazine salt
acefyllinpiperazinum
acefyllinum piperazinum [inn-latin]
etaphydel
acefylline piperazine [inn:ban:dcf]
acefilina piperazina
12i91ios6z ,
acefyllinum piperazinum
acefillina piperazina
unii-12i91ios6z
einecs 227-160-6
epicophylline
acefylline piperazine [mart.]
acefylline compd with piperazine
acefylline compd with piperazine [mi]
acefylline piperazine [inn]
acefylline piperazine [who-dd]
75-78% acefylline and 22-25% piperazine
Q27251411

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Minophylline (theophylline ethanoate of piperazine) and aminophylline (theophylline ethylenediamine) were determined spectrophotometrically in dosage forms without interference from excipients and/or preservatives."( Spectrophotometric determination of theophylline formulations.
Abdine, H; Elsayed, MA; Elsayed, YM, 1979
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (44.44)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]